explore | Grilled Cheese

Signal or noise? > Beacon Therapeutics Reports Positive Topline Data from the
Pivotal VISTA Trial of Laru-zova for the Treatment of X-linked
Retinitis Pigmentosa (XLRP)… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #pharma #competitivemarketing

97% of UK pharmacies are worried that the new oral GLP-1 weight-loss tablet could fuel a rise in counterfeit medicines, according to Heather Clarke-Hite, director at Crane Authentication.

healthcaretoday.com/article/comm...

#GLP1 #PatientSafety #Counterfeiting #Pharma #WeightLoss

Signal or noise? > Scientists engineer a miniature CRISPR protein to silence
genes and curb hepatitis B - Bioengineer.org >> Comment below! #strategy #competitiveintelligence #marketing #pharma #competitivemarketing #biotech #healthcare #pharmaceutical

R/Pharma Workshops are just around the corner!

From Sept 28–Oct 1, join us for 25 workshops and a Pharmaverse hackathon across Europe/US and Asia Pacific timezones.

See what’s on the schedule and find registration links for all the sessions:
rinpharma.com/docs/blog/po...

#rstats #pharma #ai

Signal or noise? > Bitrobius targets mitochondrial gene delivery with £700k
ARIA grant - Laboratory News >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #competitivemarketing #healthcare #pharma

Signal or noise? > Ocugen Lays Out Three-Year FDA Roadmap as Gene Therapy
Timelines Stretch to 2028 - AD HOC NEWS >> Comment below! #strategy #competitiveintelligence #marketing #pharma #competitivemarketing #pharmaceutical #healthcare #biotech

We talk a lot about what AI should do. Less about what guardrails should exist around it.
GEO is a good example, moving so fast that even defining it is a moving target. Regulate too early and you kill it. Too late and you've lost control.
Not investing isn't an option either. 🫠 #GEO #AI #Pharma

Signal or noise? > Wisconsin sisters with rare hearing loss receive newly
approved therapy - Roanoke Times >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #competitivemarketing #biotech #pharmaceutical #pharma

Ozempic's maker just added Claude AI to its drug discovery stack, alongside OpenAI. Inside pharma's new AI race: #AIHealthcare #DrugDiscovery #Biotech #Pharma #OpenAI #ClaudeScience, #Anthropic

artificialscience.org/2026/09/novo...

Signal or noise? > Ligand Pharmaceuticals: Owning It Gives You A Stake Across
Biotech (NASDAQ:LGND) - Seeking Alpha >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #pharma #competitivemarketing #biotech

FDA approves Etcamah for Astrazeneca, 4 Sep 2026
US FDA (Drugs@FDA), 4 Sep 2026
Drugs@FDA lists Etcamah (Camizestrant 75MG) under NDA220359…
What should Astrazeneca Pharmaceuticals publish next: indication, endpoints, or timeline?

ENCLAI Daily → enclai.net/news
#ClinicalResearch #Pharma #MedSky

FDA approves Pixclara for Telix Pharmaceuticals Us, 11 Sep 2026
US FDA (Drugs@FDA), 11 Sep 2026
Drugs@FDA lists Pixclara (Floretyrosine F 18 185MBQ…
What should Telix Pharmaceuticals publish next: indication, endpoints, or timeline?

ENCLAI Daily → enclai.net/news
#ClinicalResearch #Pharma #MedSky

FDA approves Isembyld (Apitegromab-Mstn) for Scholar Rock, 11 Sep 2026
US FDA (Drugs@FDA), 11 Sep 2026
Drugs@FDA lists Isembyld (Apitegromab-Mstn 150MG/3ML (50MG/ML))…
Does this match what teams working with Scholar Rock are seeing?

ENCLAI Daily → enclai.net/news
#ClinicalResearch #Pharma #MedSky

Pfizer: 4,670-patient Phase 3 pneumococcal disease trial registered
ClinicalTrials.gov, 26 Aug 2026
On 26 Aug 2026 Pfizer registered NCT07794748, a phase 3…
What should Pfizer publish next: indication, endpoints, or timeline?

ENCLAI Daily → enclai.net/news
#ClinicalResearch #Pharma #MedSky

BioNTech SE: 700-patient Phase 3 COVID-19 vaccines trial registered
ClinicalTrials.gov, 28 Aug 2026
On 28 Aug 2026 BioNTech SE registered NCT07798648, a phase 3…
Does this match what teams working with Biontech are seeing?

ENCLAI Daily → enclai.net/news
#ClinicalResearch #Pharma #MedSky

Chia Tai Tianqing: Phase 3 chronic hepatitis trial, 930 patients
ClinicalTrials.gov, 28 Aug 2026
On 28 Aug 2026 Chia Tai Tianqing…
Does this match what teams working with Chia Tai Tianqing Pharmaceutical Group are seeing?

ENCLAI Daily → enclai.net/news
#ClinicalResearch #Pharma #MedSky

GlaxoSmithKline: 54,000-patient Phase 3 influenza trial registered
ClinicalTrials.gov, 1 Sep 2026
On 1 Sep 2026 GlaxoSmithKline registered NCT07805707, a phase 3…
Routine step or a change of direction? What would settle it?

ENCLAI Daily → enclai.net/news
#ClinicalResearch #Pharma #MedSky

Hoffmann-La Roche: 325-patient Phase 3 influenza trial registered
ClinicalTrials.gov, 15 Sep 2026
On 15 Sep 2026 Hoffmann-La Roche registered NCT07827599, a phase 3…
Routine step or a change of direction? What would settle it?

ENCLAI Daily → enclai.net/news
#ClinicalResearch #Pharma #MedSky

Signal or noise? > Wisconsin sisters with rare hearing loss receive newly
approved therapy - STLtoday.com >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #competitivemarketing #biotech #pharmaceutical #pharma